PTRH2 and breast carcinoma: To address the biological significance of Bit1 downregulation in the aggressive phenotype of breast tumor cells, we suppressed Bit1 expression in the lowly aggressive mammary carcinoma MCF7 cell line which exhibits moderate levels of endogenous Bit1 (Figure 2A).